KRISTEN RITCH: Open Payments
NPI 1609113380 · LEESBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$898 in 19 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $382 · 2025 $898
Food & beverage: $898
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 2 | $258 |
| UCB, Inc. | 3 | $183 |
| Novartis Pharmaceuticals Corporation | 2 | $151 |
| GENZYME CORPORATION | 2 | $56 |
| REVANCE THERAPEUTICS, INC. | 1 | $50 |
| Janssen Biotech, Inc. | 1 | $37 |
| Incyte Corporation | 1 | $29 |
| Lilly USA, LLC | 1 | $25 |
| Biofrontera Inc. | 1 | $25 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $23 |
Products named: DUPIXENT, Bimzelx, DAXXIFY, TREMFYA, COSENTYX, OPZELURA, TALTZ, AMELUZ.
Industry payments across VA — which companies pay providers there.
